Inpeco S.A. recalls FlexLab X (FXX) System and 1 more
- Published
- 15 Oct 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
FlexLab X (FXX) System. Potassium Test System. in vitro diagnostic
FlexLab (FLX) System. Potassium Test System. in vitro diagnostic
- Brand / company
- Inpeco S.A.
- Codes / lots
- PN: FLX-056-40; UDI: 07640172344002: Serial No. FXX.0015. | PN: FLX-056-01, FLX-056-11; UDI: 07640172340004: Serial No. FLX.0204, FLX.0205, FLX.0209, FLX.0210, FLX.0216, FLX.0220, FLX.0221, FLX.0222.
- Distribution
- US distribution to CA & NY.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 15 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.